Lawrence J. Jasinski's most recent trade in Lemaitre Vascular Inc was a trade of 1 Dividend Equivalent Rights done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 1 | 5 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 1 | 2 | - | - | Dividend Equivalent Rights | |
| Rewalk Robotics Ltd. | Lawrence J. Jasinski | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.26 per share. | 21 May 2025 | 1,909 | 98,728 (0%) | 0% | 1.3 | 2,405 | Ordinary Shares, par value NIS 1.75 per share |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 1 | 1 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Sale of securities on an exchange or to another person at price $ 92.00 per share. | 04 Mar 2025 | 3,142 | 2,607 (0%) | 0% | 92 | 289,064 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 204 | 5,748 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 1 | 5,749 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 1 | 3 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | J. Jasinski Lawrence | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 6 | 5,538 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | J. Lawrence Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 6 | 1 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | J. Jasinski Lawrence | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 3 | 5,544 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 3 | 5,541 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Jasinski Lawrence J. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 3 | 5 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 3 | 4 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 1 | 5,532 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 1 | 3 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 2,594 | 2,594 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 420 | 5,531 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Sale of securities on an exchange or to another person at price $ 103.50 per share. | 20 Nov 2024 | 198 | 5,111 (0%) | 0% | 103.5 | 20,493 | Common Stock |
| Rewalk Robotics Ltd. | Lawrence J. Jasinski | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.26 per share. | 13 Sep 2024 | 2,672 | 100,637 (0%) | 0% | 3.3 | 8,700 | Ordinary Shares, par value NIS 1.75 per share |
| Rewalk Robotics Ltd. | Lawrence J. Jasinski | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.84 per share. | 02 Aug 2024 | 2,665 | 103,309 (0%) | 0% | 3.8 | 10,234 | Ordinary Shares, par value NIS 1.75 per share |
| Rewalk Robotics Ltd. | Lawrence J. Jasinski | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.22 per share. | 18 Jun 2024 | 3,466 | 105,974 (0%) | 0% | 4.2 | 14,617 | Ordinary Shares, par value NIS 1.75 per share |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 1 | 2 | - | - | Dividend Equivalent Rights | |
| Rewalk Robotics Ltd. | Lawrence J. Jasinski | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.91 per share. | 21 May 2024 | 1,620 | 109,440 (0%) | 0% | 4.9 | 7,954 | Ordinary Shares, par value NIS 1.75 per share |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 1 | 1 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Sale of securities on an exchange or to another person at price $ 67.50 per share. | 05 Mar 2024 | 5,110 | 5,309 (0%) | 0% | 67.5 | 344,925 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 593 | 10,418 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 1 | 10,419 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 1 | 4 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | Lawrence Jasinski J. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2023 | 2 | 9,824 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Jasinski J. Lawrence | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2023 | 2 | 6 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | Jasinski J. Lawrence | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2023 | 1 | 9,825 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2023 | 1 | 4 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 2,772 | 2,772 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | Lawrence Jasinski J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 512 | 9,822 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Jasinski J. Lawrence | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 1 | 8 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | J. Jasinski Lawrence | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 1 | 5 | - | - | Dividend Equivalent Rights | |
| Rewalk Robotics Ltd | Lawrence J. Jasinski | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 20 Jun 2023 | 22,920 | 566,513 (4%) | 0% | 0.6 | 13,564 | Ordinary Shares, par value NIS 0.25 per share |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 1 | 2 | - | - | Dividend Equivalent Rights | |
| Rewalk Robotics Ltd | Lawrence J. Jasinski | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 22 May 2023 | 11,457 | 589,433 (4%) | 0% | 0.6 | 6,980 | Ordinary Shares, par value NIS 0.25 per share |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Sale of securities on an exchange or to another person at price $ 66.00 per share. | 09 May 2023 | 3,648 | 9,310 (0%) | 0% | 66 | 240,768 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.48 per share. | 09 May 2023 | 2,500 | 11,810 (0%) | 0% | 35.5 | 88,700 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.60 per share. | 09 May 2023 | 1,148 | 12,958 (0%) | 0% | 48.6 | 55,793 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2023 | 1,148 | 2,296 | - | - | Stock Option (Right to Buy) | |
| Rewalk Robotics Ltd | Lawrence J. Jasinski | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.66 per share. | 27 Mar 2023 | 196 | 600,890 (4%) | 0% | 0.7 | 129 | Ordinary Shares, par value NIS 0.25 per share |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2023 | 1 | 1 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2023 | 1 | 5 | - | - | Dividend Equivalent Rights | |
| Rewalk Robotics Ltd | Lawrence J. Jasinski | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.72 per share. | 15 Mar 2023 | 15,000 | 15,000 (0%) | 0% | 0.7 | 10,811 | Ordinary Shares, par value NIS 0.25 per share |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 02 Mar 2023 | 192 | 9,310 (0%) | 0% | 50 | 9,600 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 3,209 | 3,209 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2022 | 593 | 9,502 (0%) | 0% | 0 | Common Stock | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Sale of securities on an exchange or to another person at price $ 47.07 per share. | 01 Dec 2022 | 10,000 | 8,909 (0%) | 0% | 47.1 | 470,697 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 5,000 | 2,500 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.29 per share. | 01 Dec 2022 | 5,000 | 18,909 (0%) | 0% | 37.3 | 186,450 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.56 per share. | 01 Dec 2022 | 2,500 | 11,409 (0%) | 0% | 23.6 | 58,900 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 2,500 | 2,500 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.48 per share. | 01 Dec 2022 | 2,500 | 13,909 (0%) | 0% | 35.5 | 88,700 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2022 | 1 | 4 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2022 | 1 | 3 | - | - | Dividend Equivalent Rights | |
| Rewalk Robotics Ltd | Lawrence J. Jasinski | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 200,000 | 601,086 (4%) | 1% | 0 | Ordinary Shares, par value NIS 0.25 per share | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 1 | 2 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 1 | 1 | - | - | Dividend Equivalent Rights | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2021 | 3,444 | 3,444 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 48.60 per share. | 11 Dec 2021 | 576 | 8,909 (0%) | 0% | 48.6 | 27,994 | Common Stock |
| Rewalk Robotics Ltd | Lawrence J. Jasinski | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.87 per share. | 01 Jul 2021 | 22,797 | 401,086 (3%) | 0% | 0.9 | 19,833 | Ordinary Shares, par value NIS 0.25 per share |
| Rewalk Robotics Ltd | Lawrence J. Jasinski | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.88 per share. | 01 Jul 2021 | 11,400 | 423,883 (3%) | 0% | 0.9 | 10,032 | Ordinary Shares, par value NIS 0.25 per share |
| Rewalk Robotics Ltd | Lawrence J. Jasinski | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.13 per share. | 01 Jul 2021 | 220 | 435,283 (3%) | 0% | 1.1 | 249 | Ordinary Shares, par value NIS 0.25 per share |
| Rewalk Robotics Ltd | Lawrence J. Jasinski | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.57 per share. | 01 Jul 2021 | 87 | 435,503 (3%) | 0% | 1.6 | 137 | Ordinary Shares, par value NIS 0.25 per share |
| Rewalk Robotics Ltd | Lawrence J. Jasinski | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.69 per share. | 21 Jun 2021 | 22,500 | 435,566 (3%) | 0% | 1.7 | 38,025 | Ordinary Shares, par value NIS 0.25 per share |
| Rewalk Robotics Ltd | Lawrence J. Jasinski | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 150,000 | 458,066 (3%) | 1% | 0 | Ordinary Shares, par value NIS 0.25 per share | |
| Rewalk Robotics Ltd | Lawrence J. Jasinski | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.90 per share. | 04 May 2021 | 148 | 308,066 (2%) | 0% | 1.9 | 281 | Ordinary Shares, par value NIS 0.25 per share |
| Rewalk Robotics Ltd | Lawrence J. Jasinski | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.38 per share. | 27 Mar 2021 | 202 | 308,214 (2%) | 0% | 2.4 | 481 | Ordinary Shares, par value NIS 0.25 per share |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Sale of securities on an exchange or to another person at price $ 51.28 per share. | 01 Mar 2021 | 7,500 | 8,333 (0%) | 0% | 51.3 | 384,567 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.48 per share. | 01 Mar 2021 | 2,500 | 15,833 (0%) | 0% | 35.5 | 88,700 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 2,500 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 2,500 | 2,500 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.30 per share. | 01 Mar 2021 | 2,500 | 10,833 (0%) | 0% | 31.3 | 78,250 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.56 per share. | 01 Mar 2021 | 2,500 | 13,333 (0%) | 0% | 23.6 | 58,900 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2020 | 7,500 | 7,500 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Sale of securities on an exchange or to another person at price $ 39.50 per share. | 24 Nov 2020 | 7,500 | 8,333 (0%) | 0% | 39.5 | 296,250 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.30 per share. | 24 Nov 2020 | 5,000 | 13,333 (0%) | 0% | 31.3 | 156,500 | Common Stock |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2020 | 5,000 | 2,500 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2020 | 2,500 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Lemaitre Vascular Inc | Lawrence J. Jasinski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.56 per share. | 24 Nov 2020 | 2,500 | 15,833 (0%) | 0% | 23.6 | 58,900 | Common Stock |
| Rewalk Robotics Ltd | Lawrence J. Jasinski | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.06 per share. | 05 Oct 2020 | 348 | 308,416 (2%) | 0% | 1.1 | 369 | Ordinary Shares, par value NIS 0.25 per share |